Company: SRFM
Filing Date: 2025-02-11
Form Type: S-3
Source: 0000950170-25-018075
Chunk: 15

Company: SURF AIR MOBILITY INC.
Filing Date: 2025-02-11
Form: S-3
Chunk 15
---
 listing standards. The NYSE will review us on a quarterly basis to confirm compliance with the plan. If we fail to comply with the plan or do not meet the continued listing standards at the end of the 18-month cure period, we will be subject to the prompt initiation of NYSE suspension and delisting procedures.

There can be no assurance that we will be able to regain compliance with the NYSE’s continued listing requirements. If our stock price does not increase and if our market capitalization or stockholders’ equity does not meet the minimum standards, we may not be able to meet the standards for continued listing on the NYSE within the compliance period. In the event that we do not regain compliance with the NYSE continued listing standards, we and our stockholders could face significant material adverse consequences, including:

being delisted from the NYSE;

a limited availability of market quotations for our common stock;

an adverse effect on the market price of our common stock;

loss of confidence from stakeholders, employees and potential business partners;

reduced liquidity with respect to our common stock;

<div align='center'>9</div>

a determination that our shares are a “penny stock,” which will require brokers trading in our shares to adhere to more stringent rules, and which may limit demand for our common stock among certain investors;

a limited amount or complete absence of news and analyst coverage for our company; and

a decreased ability or inability to issue additional securities or obtain additional financing in the future.

<div align='center'>10

USE OF PROCEEDS</div>

Unless otherwise specified in an accompanying prospectus supplement, we will use the net proceeds we receive from the sale of the securities covered by this prospectus for general corporate purposes, which may include, among other things, paying or refinancing all or a portion of our indebtedness at the time and funding acquisitions, capital expenditures and working capital. Net proceeds may be temporarily invested prior to use.

The actual application of the net proceeds from the sale of any particular offering of securities using this prospectus will be described in the applicable prospectus supplement relating to such offering.

<div align='center'>11

DESCRIPTION OF CAPITAL STOCK</div>

The following is a summary of the material terms of our capital stock. The summary does not purport to be complete, and is subject to and qualified its entirety by reference to our amended and restated certificate of incorporation (the “Amended and Restated Certificate of Incorporation”) and our amended and restated bylaws (the “Amended and Restated By